Pharming Group NV (PHAR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $891.80M
Last updated: Nov 17, 2026 at 4:15 PM ET
Pharming Group NV (PHAR) Stock Chart
Pharming Group NV (PHAR) has a latest price of $12.06 on Nov 17, 2026, 43.5% below its 52-week high of $21.34. Its price fell 28.3% over the past 12 months. The month-end price rose 35.9% over the 5 years through Oct 2026, a compound annual rate of 6.3%.
Price Chart
From Dec 2020 to Oct 2026, its highest month-end close was $20.47 in Jan 2026 and its lowest $7.35 in Nov 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PHAR with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PHAR.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 1.8%, and over 6 months it fell 4.3%. The month-end price rose 3.1% over the 3 years through Oct 2026, a compound annual rate of 1.0%.
| Period | Change |
|---|---|
| 1 month | +32.4% |
| 3 months | +1.8% |
| 6 months | -4.3% |
| 12 months | -28.3% |
| 12 months, with dividends | -28.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +3.1% | +1.0% |
| 5 years | +35.9% | +6.3% |
Price by Year
Its best calendar year was 2025, when the price rose 75.6%, and its weakest was 2021, when it fell 41.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $12.23 | -30.8% |
| 2025 | $17.67 | +75.6% |
| 2024 | $10.06 | -11.9% |
| 2023 | $11.43 | +3.6% |
| 2022 | $11.03 | +23.4% |
| 2021 | $8.94 | -41.2% |
Trading Range
The price is 9.7% above its 50-day average of $11.00 and 9.9% below its 200-day average of $13.38.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $12.06 | |
| 52-week high | $21.34 | -43.5% |
| 52-week low | $9.11 | +32.4% |
| 50-day average | $11.00 | +9.7% |
| 200-day average | $13.38 | -9.9% |
Price Risk
Over 3 years, its largest fall from a peak was 57.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.90 |
| Largest fall, 1 year | -57.0% |
| Largest fall, 3 years | -57.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PHAR
What is PHAR's 1-year price change?
Pharming Group NV's price fell 28.3% over the past 12 months. With dividends included, the 12-month total return was -28.3%.
What is PHAR's 5-year price change?
Pharming Group NV's month-end price rose 35.9% over the 5 years through Oct 2026, a compound annual rate of 6.3%. These figures leave out dividends.
What is PHAR's 52-week high and low?
Pharming Group NV's 52-week high is $21.34 and its 52-week low is $9.11. Its latest price of $12.06 on Nov 17, 2026 is 43.5% below the high.
What is PHAR's beta?
Pharming Group NV's 1-year beta against the S&P 500 is 0.90, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 57.0%.
Is the PHAR chart free?
Yes. Advanced Charting for PHAR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PHAR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors